- Report
- October 2023
- 123 Pages
From €3280EUR$3,450USD£2,755GBP
- Report
- October 2023
- 146 Pages
Europe
From €3280EUR$3,450USD£2,755GBP
- Report
- October 2023
- 142 Pages
Asia Pacific
From €3280EUR$3,450USD£2,755GBP
- Report
- February 2024
- 197 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- January 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- September 2022
- 120 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2023
- 146 Pages
Global
From €3353EUR$3,528USD£2,817GBP
€3945EUR$4,150USD£3,314GBP
- Report
- July 2024
- 113 Pages
Global
From €3500EUR$3,944USD£3,043GBP
The Structural Heart Device market is a subset of the Cardiovascular Devices market, which includes products used to diagnose and treat cardiovascular diseases. Structural Heart Devices are used to treat structural heart defects, such as atrial septal defects, patent foramen ovale, and mitral valve regurgitation. These devices are typically implanted in the heart and can include transcatheter aortic valve replacement (TAVR) devices, occluders, and annuloplasty rings.
Structural Heart Devices are used to improve patient outcomes and reduce the need for open-heart surgery. They are also used to reduce the risk of stroke and other complications associated with structural heart defects.
Some companies in the Structural Heart Device market include Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, and St. Jude Medical. Show Less Read more
